CARMOT THERAPEUTICS
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, Chemotype Evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies. Carmot Therapeutics is headquartered in San Francisco, California and was founded in 2008.
CARMOT THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.carmot-therapeutics.us
Total Employee:
1+
Status:
Active
Contact:
5105279251
Email Addresses:
[email protected]
Total Funding:
234.85 M USD
Technology used in webpage:
SPF Google Apps For Business Unified Layer BlueHost BlueHost DNS BlueHost Mail
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Willett Advisors LLC
Willett Advisors LLC investment in Series D - Carmot Therapeutics
Deep Track Capital
Deep Track Capital investment in Series D - Carmot Therapeutics
The Column Group
The Column Group investment in Series D - Carmot Therapeutics
RA Capital Management
RA Capital Management investment in Series D - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series D - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series C - Carmot Therapeutics
The Column Group
The Column Group investment in Series C - Carmot Therapeutics
Amgen Ventures
Amgen Ventures investment in Series C - Carmot Therapeutics
The Column Group
The Column Group investment in Series B - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series B - Carmot Therapeutics
Official Site Inspections
http://www.carmot-therapeutics.us Semrush global rank: 5.15 M Semrush visits lastest month: 1.57 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Carmot Therapeutics"
Carmot Therapeutics - Crunchbase Company Profile
Carmot Therapeutics may be growing as evidenced by the acquisition by Roche for up to $3.1 billion, which is a significant financial transaction indicating a โฆSee details»
Carmot Therapeutics, Inc. - LinkedIn
Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes.See details»
Carmot Therapeutics 2025 Company Profile: Valuation, โฆ
Information on acquisition, funding, cap tables, investors, and executives for Carmot Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Genentech: Carmot Therapeutics
Carmot is currently conducting a multi-center, randomized, placebo-controlled Phase 2 clinical trial of CT-868 in participants with overweight/obesity and T1D to assess efficacy, safety, tolerability, and pharmacokinetics.See details»
Carmot Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Carmot Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Carmot Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Carmot Therapeutics Inc. of Berkeley, CA. Get the latest business insights from Dun & Bradstreet.See details»
CARMOT THERAPEUTICS: Revenue, Worth, Valuation
About CARMOT THERAPEUTICS CARMOT THERAPEUTICS is a Services company that has established a notable presence through consistent innovation and market adaptability with a โฆSee details»
Organization | Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. Report issue For profit Phase 1 Phase 2 Founded: SAN FRANCISCO CA United States (2008) Status: Acquired by Roche (2023) Organization Overview First โฆSee details»
Carmot - 2025 Company Profile & Team - Tracxn
Jun 21, 2025 Carmot is an acquired company based in Berkeley (United States), founded in 2008 by Stig Hansen and Daniel Erlanson. It operates as a Developer of disease-modifying โฆSee details»
Carmot Therapeutics Company Profile - Office Locations ... - Craft
See insights on Carmot Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Carmot Therapeutics Company Profile | Management and
Carmot Therapeutics Profile and History Carmot Therapeutics ("Carmot") is a biotechnology company dedicated to the discovery and development of innovative medicines. Carmot applies โฆSee details»
Carmot Therapeutics Announces Completion of Acquisition by โฆ
BERKELEY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for โฆSee details»
Carmot Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 2, 2023 Carmot Therapeutics is a biopharmaceutical company that focuses on creating new drugs to treat metabolic diseases, cancer, and inflammation. Their unique technology allows โฆSee details»
Roche agrees to acquire Carmot Therapeutics for $2.7bn
Dec 4, 2023 Roche has signed an agreement for the acquisition of US-based company Carmot Therapeutics in a deal valued at $2.7bn, to be paid in cash.See details»
Carmot Therapeutics (USA) Funding: $544.8M - medicalstartups.org
May 15, 2025 USA | Funding: $544.8M (+) Website: https://carmot-therapeutics.us Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.See details»
Carmot Therapeutics Company Information - Funding, Investors, โฆ
Get information on funding, investors, industries, and more for Carmot Therapeutics. See Carmot Therapeutics company profile and funding data.See details»
Carmot Therapeutics - Leadership Team | The Org
The Leadership Team at Carmot Therapeutics comprises senior executives and co-founders committed to guiding the company's strategic direction in the discovery and development of โฆSee details»
How Does Carmot Therapeutics Work? โ CANVAS, SWOT, PESTEL โฆ
Oct 2, 2024 Carmot Therapeutics is a cutting-edge biotechnology company revolutionizing the field of drug discovery through its innovative approach. Unlike traditional methods that rely on โฆSee details»
Carmot Therapeutics closes $160 million Series D financing to โฆ
Jul 26, 2022 Carmot Therapeutics is among the leading companies in leveraging dual incretin receptor modulation and CT-388 has the potential to be best-in-class.See details»
Carmot Therapeutics-Carmot Therapeutics, Inc.-ไผไธ่ฏฆๆ โฆ
Dec 31, 2014 Carmot Therapeutics, Inc. provides drugs to treat inflammatory, metabolic, and neurological diseases. The company was founded in 2008 and is based in San Francisco, โฆSee details»